Investigational drug · Phase 2
RAD101
Also called: 18F-FPIA
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Brain Metastases From Solid Tumors.
Phase 2Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "RAD101"
First trial start
2024
Dec 13, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "RAD101", any sponsor or status.
Conditions studied
As listed on its trial records.
- Brain Metastases From Solid Tumors
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "RAD101" as an intervention, largest first.
- Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesActive, not recruiting
Radiopharm Theranostics, LtdIndustry
NCT06777433 · 30 participants (planned) · Start Dec 13, 2024 · Primary completion Apr 23, 2026
Drug: RAD101 (18F-FPIA) · For: Brain Metastases From Solid Tumors
Sites: Hoffman Estates, Illinois; Goshen, Indiana; Ann Arbor, Michigan · 5 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- An improved fully-automated GMP radiosynthesis of [18F]fluoro-pivalic acid with solid-phase extraction purification.
Barnes C, Twyman F, Awais RO, et al. · EJNMMI Radiopharm Chem 2026
- Implemented one-pot two step fully automated synthesis of [18F]FPIA for metabolic imaging applications.
Enriquez JS, Paolillo V, Armijo R, et al. · Nucl Med Biol 2026
- Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging.
Vassileva V, Braga M, Barnes C, et al. · Biomedicines 2021
- Clinical translation of 18F-fluoropivalate - a PET tracer for imaging short-chain fatty acid metabolism: safety, biodistribution, and dosimetry in fed and fasted healthy volunteers.
Dubash SR, Keat N, Kozlowski K, et al. · Eur J Nucl Med Mol Imaging 2020
- Molecular cloning of the RAD10 gene of Saccharomyces cerevisiae.
Prakash L, Dumais D, Polakowska R, et al. · Gene 1985
- Molecular mechanisms of pyrimidine dimer excision in Saccharomyces cerevisiae: excision of dimers in cell extracts.
Reynolds RJ, Love JD, Friedberg EC · J Bacteriol 1981
Also in development for Brain Metastases From Solid Tumors
- Intracerebroventricular of MT027 UCAR-T Cell targeting B7H3Phase 22 trials
T-MAXIMUM Pharmaceutical Inc · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Brain Metastases From Solid Tumors
- IAM1363Phase 21 trial
Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer
- JBI-778Phase 21 trial
Jubilant Therapeutics Inc. · Brain Metastases From Solid Tumors, Leptomeningeal Disease, High Grade Glioma (HGG)
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.